ArcBest ARCB Q1 2026 Earnings EPS Surges Past Estimates in Modest Volume Environment KLXE Q1 2026 Earnings NarrowerThanExpected Loss Fails to Stem Stock Decline Lexaria Bioscience Corp LEXX Q1 2026 Earnings EPS Beat by 38 Despite No Revenue ACRE Q1 2026 Earnings Disappointing EPS Miss Amidst Challenging Commercial Real Estate Market BioAge Labs Q1 2026 Earnings Narrower Loss Delivers Positive Surprise as PreRevenue Biotech Advances Pipeline FITB Q1 2026 Earnings Strong EPS Surprise of 35 Powered by Core Operations